SCHEMBL8717261

SCHEMBL8717261

CCOC(=O)CN(CC1CC1)C(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
CTSK P43235 3/20 0.40
CTSS P25774 2/20 0.40
CACNA1B Q00975 4/20 0.39
CYP2D6 P10635 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
F7 P08709 1/20 0.36
AAK1 Q2M2I8 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7294947 0.85 CTSK (0.45) CTSKCTSSCACNA1BCYP2D6AAK1
SCHEMBL8230752 0.84 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7572754 0.82 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7330812 0.81 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7323221 0.81 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7396130 0.81 SMN1; SMN2 (0.47) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL6825598 0.80 F7 (0.40) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7332029 0.80 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7331692 0.80 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7301321 0.80 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19HTTCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5763604-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1998-06-09 US disclosed
US-5677448-A CHEMICAL INTERMEDIATES FOR MAKING ANTAGONIST OF THROMBIN, TREATING THROMBOSIS, STROKE, INFLAMMATION, ARTERIOSCLEROSIS, CARDIOVASCULAR DISORDERS HOFFMANN-LA ROCHE INC. (US) 1997-10-14 US disclosed
US-5578594-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1996-11-26 US disclosed
US-5405854-A Anticoagulants HOFFMANN-LA ROCHE INC. (US) 1995-04-11 US disclosed